Journal profile · Clinical Neurology
NEUROMODULATION
ISSN 1094-7159 · eISSN 1525-1403 · Wiley-Blackwell Publishing Ltd · UNITED STATES · Quarterly · Founded 1998
NEUROMODULATION: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 3.53; hybrid open access; APC about USD 4,110; median 88 days to acceptance (101 articles, last 24 months); community-reported acceptance: easy; 1,131 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
NEUROMODULATION is published by Wiley-Blackwell Publishing Ltd and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Pain Management and Treatment, Transcranial Magnetic Stimulation Studies and Neurological disorders and treatments, together about 40.6% of its articles. Its main subfields are Neurology. (generated from OpenAlex topic counts and CAS ranking data)
Neuromodulation: Technology at the Neural Interface is the preeminent journal in the area of neuromodulation, providing our readership with state of the art clinical, translational, and basic science research in the field. For clinicians, engineers, scientists, and members of the medical device industry alike, Neuromodulation provides timely and rigorously peer-reviewed articles on the technology, science, and clinical application of devices that interface with the nervous system to treat disease, alleviate symptoms, and improve function. Representing the needs of the broad neuromodulation community, the journal serves as an instrument for exchanging high-quality data, advancing science, and as a forum for debate and commentary. Neuromodulation covers an ever-expanding field including pain, headache, movement disorders, spasticity, paralysis, psychiatric and cognitive disorders, epilepsy, sensory deprivation, cardiovascular, gastrointestinal, and genitourinary disorders among others. As the official journal of the International Neuromodulation Society (INS), it represents the international practice of neuromodulation, a growing, diverse multidisciplinary field responsible for the development and application of both invasive and non-invasive devices and techniques to benefit individuals by normalizing or augmenting function and reducing the impact of disease. In-depth reviews, original articles, national and international meeting abstracts, special focus editions, and web-based and social media educational offerings help the reader to expand their knowledge and understanding of the interface between electrical stimulation, chemical neuromodulation and the nervous system. Our updates on past and future news of events and activities of the INS and its membership keep the reader abreast of issues related to professional education and development in this dynamic field.
From the journal's Aims & Scope
Research area (LetPub): Clinical Neurology
Editor-in-chief Robert M. LevyPublisher website
Editorial board by country: 2 in mainland China (about 2%); most named United States 54, United Kingdom 12, Belgium 7, Netherlands 4, Canada 3 (99 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Pain Management and TreatmentMedicine22.3%
- Transcranial Magnetic Stimulation StudiesNeuroscience10.1%
- Neurological disorders and treatmentsMedicine8.2%
- Pain Mechanisms and TreatmentsMedicine6.5%
- Musculoskeletal pain and rehabilitationMedicine6.2%
- Spine and Intervertebral Disc PathologyMedicine5.3%
- Vagus Nerve Stimulation ResearchNeuroscience4.9%
- Botulinum Toxin and Related Neurological DisordersMedicine4.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Clinical Neurology | Zone 3 |
| Minor | Medicine, Research & Experimental | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Medicine, Research & Experimental | Zone 2 |
| Minor | Clinical Neurology | Zone 2 |
| Minor | Neurosciences | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Clinical Neurology | Zone 3 |
| Minor | Medicine, Research & Experimental | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
PubMedPublisher website
Other: Crossref
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.53LetPub ·
- Impact factor (publisher)
- 3.7Publisher website ·
- CiteScore 2026-06
- 7.3LetPub ·
- CiteScore (publisher)
- 7.3Publisher website ·
- SJR 2026-06
- 1.08LetPub ·
- SNIP 2026-06
- 1.32LetPub ·
- h-index
- 51LetPub ·
- h-index
- 97OpenAlex ·
- i10-index
- 1,568OpenAlex ·
- 2-year mean citedness
- 0.61OpenAlex ·
- Self-citation rate
- 8.1%LetPub ·
- Share of gold OA articles
- 29.93%LetPub ·
Volume
- Articles per year
- 133LetPub ·
Articles by year OpenAlex count · 6,675 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 555 | 86 | 42 |
| 2025 | 1,131 | 108 | 391 |
| 2024 | 649 | 73 | 983 |
| 2023 | 888 | 95 | 1,554 |
| 2022 | 982 | 142 | 3,219 |
| 2021 | 213 | 96 | 2,998 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
88 daysMedian, submission to acceptance · P25–P75 66 days – 110 days
- Acceptance to online
- median 23 days (101 articles)
- Submission to online
- median 116 days
- Sample
- 101 articles with submission and acceptance dates (390 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Submission to first decision
- 6 daysPublisher website ·
- First decision after review
- 34 daysPublisher website ·
- Submission to acceptance
- 88 daysPublisher website ·
- Peer review
- Single-anonymous peer reviewPublisher website · model-extracted
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,110 / EUR 3,840 / GBP 3,290 / JPY 509,760 | — | — | |
| Publisher website | USD 4,320 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
Other charges and waivers (author guidelines)
- Colour charges
- USD 650
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare3 items from the author guidelines
- Keywords
- ≥ 5
- Reference style
- AMA
- Not considered
- materials submitted or in preparation
Article types accepted1, with length limits
- letters to the editort Template. ____4. Clinical Letters and Letters to the Editor (to include Case reports and Technical Notes) submissions are not to exceed 2 authors, 1,500 words…main text ≤ 1,500 words
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Publication ethics, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI in scientific writing
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Authorship
Author rights Model summary
Neuromodulation: Technology at the Neural Interface bases its authorship criteria on those outlined by the International Committee of Medical Journal Editors' (ICMJE) Uniform Requirements for Manuscripts Submitted to Biomedical Publications (https://www.icmje.org/ethical_1author.html). The corresponding author must submit the manuscript, related files, and all required data and information. From t…
Source ↗Publisher website ·- Conflicts of interest Disclosure instructions
Authors must disclose the use of AI and AI-assisted technologies in the writing process by adding a statement at the end of their manuscript in a new section entitled "Declaration of AI and AI-assisted technologies in the writing process." Statement: During the preparation of this work the author(s) used [NAME TOOL/SERVICE] in order to [REASON]. After using this tool/service, the author(s) reviewe…
Source ↗Publisher website ·- Publication ethics
Ethics in publishing Model summary
Please see our information on Ethics in publishing.
Source ↗Publisher website ·- License & copyright Copyright
Copyright Model summary
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (see more information on this). An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.Subscribers may reproduce tables of contents or prepare lists of articles includ…
Source ↗Publisher website ·- Open access Open access
Funding body agreements and policies Model summary
This journal offers authors a choice in publishing their research:Subscription• Articles are made available to subscribers as well as developing countries and patient groups through our universal access programs.• No open access publication fee payable by authors.• The Author is entitled to post the accepted manuscript in their institution's repository and make this public after an embargo period …
Source ↗Publisher website ·- Peer review Peer Review
Neuromodulation: Technology at the Neural Interface is a rigorously peer-reviewed journal. Upon submission, each manuscript undergoes a preliminary review by the Editor-in-Chief and, if the submission is felt to be appropriate for Neuromodulation, the Editor assigns the manuscript to a Section Editor, based upon subject matter.The Section Editors are responsible for determining if the submission p…
Source ↗Publisher website ·- Preprints Preprint references
Where a preprint has subsequently become available as a peer-reviewed publication, the formal publication should be used as the reference. If there are preprints that are central to your work or that cover crucial developments in the topic, but are not yet formally published, these may be referenced. Preprints should be clearly marked as such, for example by including the word preprint, or the nam…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley-Blackwell Publishing Ltd
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Quarterly
- Founded
- 1998
- ISSN
- 1094-7159
- Electronic ISSN
- 1525-1403
- Society / sponsor
- International Neuromodulation Society
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about NEUROMODULATION
What CAS zone is NEUROMODULATION in?
In the 2025 upgraded edition of the CAS Journal Ranking, NEUROMODULATION is in Zone 3 of Medicine, and in Zone 3 of the minor category Clinical Neurology / Medicine, Research & Experimental. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of NEUROMODULATION?
The latest impact factor listed by LetPub is 3.53; CiteScore 7.3, h-index 97.
How long does peer review take at NEUROMODULATION?
Based on the dates recorded on 101 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 88 days (interquartile range 66–110 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of NEUROMODULATION?
According to the journal's author guidelines: Keywords: ≥ 5; Reference style: AMA. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of NEUROMODULATION based?
Of the 99 board members whose country the journal's board page names, 2 (about 2%) are in mainland China; the countries named most often are United States (54), United Kingdom (12) and Belgium (7). Counted from the institutions listed on the board page; for reference only.
Which databases index NEUROMODULATION?
According to LetPub and DOAJ records, NEUROMODULATION is indexed in SCIE and Scopus. The journal's website also lists PubMed; that list has not been checked against each database.
Is NEUROMODULATION open access, and what is the APC?
NEUROMODULATION is a hybrid journal. For open-access publication: APC about USD 4,110.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .